INTERNATIONAL PATENT: INSTITUT CURIE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, SORBONNE UNIVERSITE FILES APPLICATION FOR "COMPOSITION FOR TREATMENT OF ESTROGEN-DEPENDENT CANCER COMPRISING A METTL-3 INHIBITOR AND A TOPOISOMERASE-1 INHIBITOR"

GENEVA, Nov. 24 -- INSTITUT CURIE (26 rue d'Ulm75005 PARIS), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3 rue Michel Ange75016 PARIS), SORBONNE UNIVERSITE (21 rue de l'Ecole de Medecine75006 Paris) filed a patent application (PCT/EP2025/063002) for "COMPOSITION FOR TREATMENT OF ESTROGEN-DEPENDENT CANCER COMPRISING A METTL-3 INHIBITOR AND A TOPOISOMERASE-1 INHIBITOR" on May 13, 2025. With publication no. WO/2025/237957, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHEN, Chunlong (31 rue de la Basse Roche91140 Villebo...